Efficient use of non-steroidal anti-inflammatory drugs for treatment of joint pain in the practice of physicians and pharmacists
Vol 11 No 4 (2024), Therapy
Vol 11 No 4 (2024)

Efficient use of non-steroidal anti-inflammatory drugs for treatment of joint pain in the practice of physicians and pharmacists

Therapy
https://doi.org/10.35339/ic.11.4.mmr
Published December 31, 2024
V.M. Meretskyi
Luhansk State Medical University, Rivne, Ukraine
https://orcid.org/0000-0002-6358-6884
I.V. Meretska
Luhansk State Medical University, Rivne, Ukraine
https://orcid.org/0000-0002-2953-903X
S.V. Redko
Rivne Medical Academy, Rivne, Ukraine
https://orcid.org/0009-0005-4277-2310
PDF

Keywords

dosage form
side effects
gastropathy
selectivity

How to Cite

Meretskyi, V., Meretska, I., & Redko, S. (2024). Efficient use of non-steroidal anti-inflammatory drugs for treatment of joint pain in the practice of physicians and pharmacists. Inter Collegas, 11(4). https://doi.org/10.35339/ic.11.4.mmr
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

In press

Background. Due to the prevalence of dystrophic degenerative diseases, the annual increase in the number of visits from young and middle-aged patients leading an active lifestyle, and the growing frequency of traumatic injuries of various origins, the problem of joint pain is particularly relevant.

Aim. To investigate the main factors influencing the effective and safe use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the treatment of joint pain syndrome.

Materials & Methods. Using the developed questionnaire, patients with articular pain syndrome were interviewed about the safety and rational use of NSAIDs.

Results & Conclusions. It was found that most often, people of working age with moderate intensity of pain syndrome sought medical care for joint pain. In one third of respondents, pain was accompanied by impaired motor activity in the joint. The largest proportion of respondents used oral systemic NSAIDs to reduce pain (46.7%), mainly non-selective сyclooxygenase inhi­bitors. A small proportion of patients (13.3%) who used NSAIDs topically preferred diclofenac, ibuprofen, and ketoprofen in the form of ointments and gels. 16.7% of respondents increased the dose of the drug on their own to achieve the desired therapeutic effect. 26.7% of patients simultaneously used several drugs from the NSAID group. However, the majority of the surveyed patients (63.3%) were not informed about the possibility of side effects associated with these drugs. A wide range of modern NSAIDs, a variety of dosage forms, high frequency and duration of use, and the potential risk of side effects require individual prescribing of drugs in this group. Prescribing timely and adequate treatment with a fast, effective and safe pain reliever remains an urgent issue in the daily practice of physicians and pharmacists.

Keywords: dosage form, side effects, gastropathy, selectivity.

Archived: https://doi.org/10.5281/zenodo.14756968

https://doi.org/10.35339/ic.11.4.mmr
PDF

References

McMahon SB, Dargan P, Lanas A, Wiffen P. The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Current Medical Research and Opinion. 2021;37(2):287-92. DOI: 10.1080/03007995.2020.1847718. PMID: 33155849.

Atzeni F, Masala IF, Sarzi-Puttini P. A review of chronic musculoskeletal pain: central and peripheral effects of diclofenac. Pain and Therapy. 2018;7:163-77. Available at: https://api.semanticscholar.org/CorpusID:46947389

Domper Arnal M-J, Hijos-Mallada G, Lanas A. Gastrointestinal and cardiovascular adverse events associated with NSAIDs. Expert Opinion on Drug Safety. 2022;21(3):373-84. DOI: 10.1080/14740338.2021.1965988. PMID: 34376069.

Gunaydin C, Bilge SS. Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med. 2018;50(2):116-21. DOI: 10.5152/eurasianjmed.2018.0010. PMID: 30002579.

Moore N. Coronary risks associated with diclofenac and other NSAIDs: An Update. Drug Saf. 2020;43:301-18. DOI: 10.1007/s40264-019-00900-8. PMID: 31916080.

Pelletier R, Bourbonnais D, Higgins J, Mireault M, Harris PG, Danino MA. Pain interference may be an important link between pain severity, impairment, and self-reported disability in participants with wrist/hand pain. J Hand Ther. 2020;33(4):562-70. DOI: 10.1016/j.jht.2019.06.001. PMID: 31481341.

Tai FWD, McAlindon ME. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clin Med (Lond). 2021;21(2):131-4. DOI: 10.7861/clinmed.2021-0039. PMID: 33762373.

Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-89. DOI: 10.1016/j.joca.2019.06.011. PMID: 31278997.

Ho KY, Cardosa MS, Chaiamnuay S, Hidayat R, Ho HQT, Kamil O, et al. Practice Advisory on the Appropriate Use of NSAIDs in Primary Care. Journal of Pain Research. 2020;113:1925-39. DOI: 10.2147/JPR.S247781. PMID: 32821151.

Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;6:CD007402. DOI: 10.1002/14651858.CD007402.pub3. PMID: 26068955.

Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4(4):CD007400. DOI: 10.1002/14651858.CD007400.pub3. PMID: 27103611.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.